The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Disease Testing Market Research Report 2024
Synopsis
Respiratory Disease Testing are clinical assessment equipment of many respiratory diseases
The global Respiratory Disease Testing market was valued at US$ 2868.6 million in 2023 and is anticipated to reach US$ 3287.1 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing.
Report Scope
The Respiratory Disease Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Disease Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fischer & Paykel
Medtronic
MGC Diagnostics Corporation
CAREstream Medical Ltd.
Becton Dickinson (Carefusion Corporation)
Koninklijke Philips N.V. (Respironics)
ResMed Company
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Disease Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Respiratory Disease Testing are clinical assessment equipment of many respiratory diseases
The global Respiratory Disease Testing market was valued at US$ 2868.6 million in 2023 and is anticipated to reach US$ 3287.1 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing.
Report Scope
The Respiratory Disease Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Disease Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fischer & Paykel
Medtronic
MGC Diagnostics Corporation
CAREstream Medical Ltd.
Becton Dickinson (Carefusion Corporation)
Koninklijke Philips N.V. (Respironics)
ResMed Company
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Disease Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Respiratory Disease Testing Market Overview
1.1 Product Overview and Scope of Respiratory Disease Testing
1.2 Respiratory Disease Testing Segment by Type
1.2.1 Global Respiratory Disease Testing Market Value Comparison by Type (2024-2030)
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Respiratory Disease Testing Segment by Application
1.3.1 Global Respiratory Disease Testing Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Others
1.4 Global Respiratory Disease Testing Market Size Estimates and Forecasts
1.4.1 Global Respiratory Disease Testing Revenue 2019-2030
1.4.2 Global Respiratory Disease Testing Sales 2019-2030
1.4.3 Global Respiratory Disease Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Respiratory Disease Testing Market Competition by Manufacturers
2.1 Global Respiratory Disease Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global Respiratory Disease Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Respiratory Disease Testing Average Price by Manufacturers (2019-2024)
2.4 Global Respiratory Disease Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Disease Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Disease Testing, Product Type & Application
2.7 Respiratory Disease Testing Market Competitive Situation and Trends
2.7.1 Respiratory Disease Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Respiratory Disease Testing Players Market Share by Revenue
2.7.3 Global Respiratory Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Disease Testing Retrospective Market Scenario by Region
3.1 Global Respiratory Disease Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Respiratory Disease Testing Global Respiratory Disease Testing Sales by Region: 2019-2030
3.2.1 Global Respiratory Disease Testing Sales by Region: 2019-2024
3.2.2 Global Respiratory Disease Testing Sales by Region: 2025-2030
3.3 Global Respiratory Disease Testing Global Respiratory Disease Testing Revenue by Region: 2019-2030
3.3.1 Global Respiratory Disease Testing Revenue by Region: 2019-2024
3.3.2 Global Respiratory Disease Testing Revenue by Region: 2025-2030
3.4 North America Respiratory Disease Testing Market Facts & Figures by Country
3.4.1 North America Respiratory Disease Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Respiratory Disease Testing Sales by Country (2019-2030)
3.4.3 North America Respiratory Disease Testing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Respiratory Disease Testing Market Facts & Figures by Country
3.5.1 Europe Respiratory Disease Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Respiratory Disease Testing Sales by Country (2019-2030)
3.5.3 Europe Respiratory Disease Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Disease Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Respiratory Disease Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Respiratory Disease Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific Respiratory Disease Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Respiratory Disease Testing Market Facts & Figures by Country
3.7.1 Latin America Respiratory Disease Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Respiratory Disease Testing Sales by Country (2019-2030)
3.7.3 Latin America Respiratory Disease Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Disease Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Disease Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Respiratory Disease Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Respiratory Disease Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Disease Testing Sales by Type (2019-2030)
4.1.1 Global Respiratory Disease Testing Sales by Type (2019-2024)
4.1.2 Global Respiratory Disease Testing Sales by Type (2025-2030)
4.1.3 Global Respiratory Disease Testing Sales Market Share by Type (2019-2030)
4.2 Global Respiratory Disease Testing Revenue by Type (2019-2030)
4.2.1 Global Respiratory Disease Testing Revenue by Type (2019-2024)
4.2.2 Global Respiratory Disease Testing Revenue by Type (2025-2030)
4.2.3 Global Respiratory Disease Testing Revenue Market Share by Type (2019-2030)
4.3 Global Respiratory Disease Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Respiratory Disease Testing Sales by Application (2019-2030)
5.1.1 Global Respiratory Disease Testing Sales by Application (2019-2024)
5.1.2 Global Respiratory Disease Testing Sales by Application (2025-2030)
5.1.3 Global Respiratory Disease Testing Sales Market Share by Application (2019-2030)
5.2 Global Respiratory Disease Testing Revenue by Application (2019-2030)
5.2.1 Global Respiratory Disease Testing Revenue by Application (2019-2024)
5.2.2 Global Respiratory Disease Testing Revenue by Application (2025-2030)
5.2.3 Global Respiratory Disease Testing Revenue Market Share by Application (2019-2030)
5.3 Global Respiratory Disease Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fischer & Paykel
6.1.1 Fischer & Paykel Corporation Information
6.1.2 Fischer & Paykel Description and Business Overview
6.1.3 Fischer & Paykel Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fischer & Paykel Respiratory Disease Testing Product Portfolio
6.1.5 Fischer & Paykel Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Respiratory Disease Testing Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 MGC Diagnostics Corporation
6.3.1 MGC Diagnostics Corporation Corporation Information
6.3.2 MGC Diagnostics Corporation Description and Business Overview
6.3.3 MGC Diagnostics Corporation Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MGC Diagnostics Corporation Respiratory Disease Testing Product Portfolio
6.3.5 MGC Diagnostics Corporation Recent Developments/Updates
6.4 CAREstream Medical Ltd.
6.4.1 CAREstream Medical Ltd. Corporation Information
6.4.2 CAREstream Medical Ltd. Description and Business Overview
6.4.3 CAREstream Medical Ltd. Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAREstream Medical Ltd. Respiratory Disease Testing Product Portfolio
6.4.5 CAREstream Medical Ltd. Recent Developments/Updates
6.5 Becton Dickinson (Carefusion Corporation)
6.5.1 Becton Dickinson (Carefusion Corporation) Corporation Information
6.5.2 Becton Dickinson (Carefusion Corporation) Description and Business Overview
6.5.3 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Product Portfolio
6.5.5 Becton Dickinson (Carefusion Corporation) Recent Developments/Updates
6.6 Koninklijke Philips N.V. (Respironics)
6.6.1 Koninklijke Philips N.V. (Respironics) Corporation Information
6.6.2 Koninklijke Philips N.V. (Respironics) Description and Business Overview
6.6.3 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Product Portfolio
6.6.5 Koninklijke Philips N.V. (Respironics) Recent Developments/Updates
6.7 ResMed Company
6.6.1 ResMed Company Corporation Information
6.6.2 ResMed Company Description and Business Overview
6.6.3 ResMed Company Respiratory Disease Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ResMed Company Respiratory Disease Testing Product Portfolio
6.7.5 ResMed Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Disease Testing Industry Chain Analysis
7.2 Respiratory Disease Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Disease Testing Production Mode & Process
7.4 Respiratory Disease Testing Sales and Marketing
7.4.1 Respiratory Disease Testing Sales Channels
7.4.2 Respiratory Disease Testing Distributors
7.5 Respiratory Disease Testing Customers
8 Respiratory Disease Testing Market Dynamics
8.1 Respiratory Disease Testing Industry Trends
8.2 Respiratory Disease Testing Market Drivers
8.3 Respiratory Disease Testing Market Challenges
8.4 Respiratory Disease Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
